SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy

Completed · Not applicable

Conditions studied: Chemotherapy-induced Peripheral Neuropathy

In brief

The main purpose of this study is to determine the threshold level of lower extremity CIPN symptoms that put patients who have been prescribed a neurotoxic chemotherapy agent (e.g., paclitaxel, docetaxel, oxaliplatin or cisplatin) as part of their treatment regimen for cancer at-risk for falling. The investigators believe that by specifying early CIPN symptoms that predict fall-risk, The investigators will ultimately be able to identify at-risk patients who could be referred to rehabilitative services to prevent injurious falls while enabling them to continue the chemotherapy treatment that could save their lives.

Key facts

Study ID

NCT05330104

Run by

Allina Health System

People needed

12

Starts

2022-01-03

Expected to finish

2025-06-16

Last updated by the study team

2026-01-27

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥ 45 years old
• New cancer diagnosis other than a primary brain tumor
• A taxane and/or platinum chemotherapy agent has been prescribed as part of the treatment regimen for cancer.
• English speaking
• Able to see, hear, speak (with or without assistive devices)
• Able to walk without an assistive device - for example: cane, walker, walking stick(s) at the start of cancer treatment
• Able to provide own transportation to study visits
• Willing and able to commit to symptom tracking three times weekly via mEMA for up to 9 months.
• Owns a smartphone with one of the following operating system versions:
• iOS 8.0 - 8.4, 9.0 - 9.3, 10.0 - 10.3, 12, 13.3 or later Android 7.0 - 7.1.2, 8.0 - 8.1.0, 9, 10 or later
• Agree to use personal smartphone to download the mEMA application and respond to application notifications.

You may not qualify if…

• Individuals who started their chemotherapy regimen greater than 4 weeks prior to study enrollment.
• Individuals being treated for a primary brain tumor

Where it is running

• Abbott Northwestern Hospital — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.